Lv56
1109 积分 2025-01-08 加入
Embracing PMI: Advancing Sustainability in Peptide Synthesis
27天前
已完结
Industrial Case Studies Demonstrating Applicability of ICH M7 Control Options 3 and 4 for Nitrosamine Control
2个月前
已完结
Best Practices for Microbial Challenge In-Use Studies to Evaluate the Microbial Growth Potential of Parenteral Biological Products; Industry and Regulatory Considerations
2个月前
已完结
Development and validation of an LC-MS/MS method for Tirzepatide, a dual GIP/GLP-1 receptor agonist, in rat plasma for application to a pharmacokinetic study
4个月前
已完结
Suppression of acute uveitis following treatment with repository corticotropin injection
6个月前
已关闭
Considerations for the Terminal Sterilization of Oligonucleotide Drug Products
7个月前
已完结
Platform Strategies for Synthetic Oligonucleotide Drug Substances
7个月前
已完结
Nitrosamine Risk Assessments in Oligonucleotides
7个月前
已完结
Perspectives on the Designation of Oligonucleotide Starting Materials
7个月前
已完结
皖公网安备34019202002308
